BACKGROUND: Chronic severe aortic regurgitation (AR) imposes significant volume and pressure overload on the left ventricle (LV), but such patients typically remain in an asymptomatic state for a very long time. OBJECTIVES: This study sought to examine long-term outcomes in a contemporary group of patients with grade III+ chronic AR and preserved left ventricular ejection fraction (LVEF) and the value of aortic valve (AV) surgery on long-term survival. We also wanted to reassess the threshold of LV dimension, beyond which mortality significantly increases. METHODS: The authors studied 1,417 such patients (mean 54 ± 16 years of age, 75% men) seen between 2002 and 2010. Clinical data were obtained and Society of Thoracic Surgeons (STS) score was calculated. The primary endpoint was mortality. RESULTS: Mean STS score was 5.5% ± 8%, and mean LVEF was 57 ± 4%, whereas 1,228 patients (87%) were asymptomatic, and 93 patients (7%) had indexed LV end-systolic dimension (iLVESD) ≥2.5 cm/m2. At 6.6 ± 3 years, 933 patients (66%) underwent AV surgery (36% isolated AV surgery, 16% concomitant coronary bypass, and 58% aortic replacement), and 262 patients (19%) died. In-hospital postoperative mortality was 2% (0.6% in isolated AV surgery). On multivariate Cox survival analysis, compared to the group of iLVESD <2.5 cm/m2 and no AV surgery, the 2 groups of iLVESD <2.5 cm/m2 with AV surgery and iLVESD ≥2.5 cm/m2 with AV surgery were associated with improved survival (hazard ratios: 0.62 and 0.42, respectively; both p < 0.01). Survival of patients who underwent AV surgery was similar to that of an age- and sex-matched U.S. population with 96% of deaths occurring in those with iLVESD <2.5 cm/m2. CONCLUSIONS: At a high-volume experienced center, patients with grade III or greater AR and preserved LVEF demonstrated significantly improved long-term survival following AV surgery. The risk of death significantly increased at a lower LV dimension threshold than previously described.
BACKGROUND: Chronic severe aortic regurgitation (AR) imposes significant volume and pressure overload on the left ventricle (LV), but such patients typically remain in an asymptomatic state for a very long time. OBJECTIVES: This study sought to examine long-term outcomes in a contemporary group of patients with grade III+ chronic AR and preserved left ventricular ejection fraction (LVEF) and the value of aortic valve (AV) surgery on long-term survival. We also wanted to reassess the threshold of LV dimension, beyond which mortality significantly increases. METHODS: The authors studied 1,417 such patients (mean 54 ± 16 years of age, 75% men) seen between 2002 and 2010. Clinical data were obtained and Society of Thoracic Surgeons (STS) score was calculated. The primary endpoint was mortality. RESULTS: Mean STS score was 5.5% ± 8%, and mean LVEF was 57 ± 4%, whereas 1,228 patients (87%) were asymptomatic, and 93 patients (7%) had indexed LV end-systolic dimension (iLVESD) ≥2.5 cm/m2. At 6.6 ± 3 years, 933 patients (66%) underwent AV surgery (36% isolated AV surgery, 16% concomitant coronary bypass, and 58% aortic replacement), and 262 patients (19%) died. In-hospital postoperative mortality was 2% (0.6% in isolated AV surgery). On multivariate Cox survival analysis, compared to the group of iLVESD <2.5 cm/m2 and no AV surgery, the 2 groups of iLVESD <2.5 cm/m2 with AV surgery and iLVESD ≥2.5 cm/m2 with AV surgery were associated with improved survival (hazard ratios: 0.62 and 0.42, respectively; both p < 0.01). Survival of patients who underwent AV surgery was similar to that of an age- and sex-matched U.S. population with 96% of deaths occurring in those with iLVESD <2.5 cm/m2. CONCLUSIONS: At a high-volume experienced center, patients with grade III or greater AR and preserved LVEF demonstrated significantly improved long-term survival following AV surgery. The risk of death significantly increased at a lower LV dimension threshold than previously described.
Authors: Elizabeth Lee; Blair Richards; Jimmy C Lu; Maryam Ghadimi Mahani; Adam L Dorfman; Sowmya Balasubramanian; Prachi P Agarwal Journal: J Comput Assist Tomogr Date: 2019 Mar/Apr Impact factor: 1.826
Authors: Christopher T Ryan; Ayman Almousa; Rodrigo Zea-Vera; Qianzi Zhang; Christopher I Amos; Joseph S Coselli; Todd K Rosengart; Ravi K Ghanta Journal: Ann Thorac Surg Date: 2021-04-25 Impact factor: 4.330
Authors: Chetan P Huded; Ahmad Masri; Kenya Kusunose; Andrew L Goodman; Richard A Grimm; A Marc Gillinov; Douglas R Johnston; L Leonardo Rodriguez; Zoran B Popovic; Lars G Svensson; Brian P Griffin; Milind Y Desai Journal: J Am Heart Assoc Date: 2018-04-12 Impact factor: 5.501
Authors: Radka Kočková; Hana Línková; Zuzana Hlubocká; Alena Pravečková; Andrea Polednová; Lucie Súkupová; Martin Bláha; Jiří Malý; Eva Honsová; David Sedmera; Martin Pěnička Journal: J Clin Med Date: 2019-10-11 Impact factor: 4.241
Authors: Nicolas Isaza; Milind Y Desai; Samir R Kapadia; Amar Krishnaswamy; L Leonardo Rodriguez; Richard A Grimm; Julijana Z Conic; Yoshihito Saijo; Eric E Roselli; A Marc Gillinov; Douglas R Johnston; Lars G Svensson; Brian P Griffin; Zoran B Popović Journal: J Am Heart Assoc Date: 2020-03-24 Impact factor: 5.501
Authors: Maan Malahfji; Alpana Senapati; Bhupendar Tayal; Duc T Nguyen; Edward A Graviss; Sherif F Nagueh; Michael J Reardon; Miguel Quinones; William A Zoghbi; Dipan J Shah Journal: J Am Heart Assoc Date: 2020-11-26 Impact factor: 5.501